For weight loss, Wegovy (injectable) is considered the most effective form of semaglutide
Understanding your individual metabolic markersweight distribution patterns, insulin response, genetic predispositions in GLP-1 and GIPR pathwaysmay help guide which provider's clinical philosophy and medication options align best with your personalized health context
Bessette and Anderson found that 89% ( 95% CI, 87.9-90.1), 88.9% (95% CI, 87.8-90) and 90.6% (95% CI, 89.5-91.6) of the cohort met the criteria for treatment with semaglutide, liraglutide (Saxenda, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly), respectively
Semaglutide is also approved for metabolic-associated steatohepatitis, a progressive form of liver disease thats closely tied to obesity